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PRACTICE MANAGEMENT
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528Peripheral occlusive disease may provide the highest
hospital margins despite rising costs
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Francis Caputo, MD,b and Nyali Taylor, MD,a Philadelphia, Pa; and Camden, NJ
Objective: The objective of this study was to review vascular surgical ﬁnancial trends in a tertiary care setting and to
evaluate the impact of a vascular program within a health care system in the face of lower reimbursements and rising costs.
Methods: With use of Current Procedural Terminology codes and diagnosis-related groups, vascular categories of aortic
disease, cerebrovascular disease, and peripheral occlusive disease (POCD) were identiﬁed at an academic tertiary health
care center. Hospital margins were calculated for each of the deﬁned categories by Health Quest cost accounting data
cross-walked with Current Procedural Terminology codes, date of service, and admitting physician for each year from
2010 to 2012.
Results: All categories realized volume growth and a positive margin for the hospital. In comparison of 2010 and 2012,
aortic cases showed an overall volume growth of 19%, revenue increase of 31%, and cost increase of 54%, resulting in an
overall margin decrease of 7%. Cerebrovascular cases showed a 30% increase in volume growth, revenue increase of 13%,
and cost increase of 5%, resulting in a margin increase of 18%. POCD cases showed overall volume growth of 35%, revenue
increase of 37%, cost increase of 54%, and a margin increase of 15%. The margin for POCD exceeded the margin for aortic
and cerebrovascular cases combined by 77%.
Conclusions: In evaluating a vascular program’s ﬁscal viability, volume-driven POCD was the only category producing
growing hospital margins in the face of signiﬁcant cost increases. (J Vasc Surg 2014;60:528-31.)The U.S. health care industry has restructured reim-
bursements in the past few decades in an attempt to
contain ever-burgeoning medical expenses, and the
shift from fee-for-service reimbursements to payment
schemes based on diagnosis-related groups (DRGs)
and relative value units has led to necessary introspection
of current practice patterns.1-4 Health systems must re-
view all aspects of their care to ensure sustainability
with goals of minimizing expenditures and maximizing
proﬁtability while still offering comprehensive medical
care to their constituents.5-8 However, many groups
and hospitals are unable to achieve these goals despite
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more challenging is ensuring quality care in the face of
such obstacles.9
Tertiary care centers with large referral bases, in-
cluding academic medical centers, are especially at risk,
given their particular need to offer all-encompassing care
for the most complex patients regardless of their ability
to pay for the services rendered.10 We have previously out-
lined the direct ﬁnancial impact of a vascular surgery pro-
gram on an academic, tertiary care center and shown that
there is signiﬁcant proﬁtability drawn from such a pro-
gram.9 To deﬁne more thoroughly those aspects of our
vascular practice that allow maximum proﬁtability, we
reviewed our surgical volume, costs, and margins during
3 years.
METHODS
This study is a retrospective review of the physician
billing database for the Division of Vascular Surgery at an
urban, academic, tertiary care center for each ﬁscal year
(FY) 2010 to 2012. We used Current Procedural Termi-
nology codes and corresponding DRGs to identify services
performed for vascular categories of aortic disease, cerebro-
vascular disease, and peripheral occlusive disease (POCD)
(Table I). Cost accounting data from Health Quest, our
accounting and billing system, were cross-walked with
Current Procedural Terminology codes and DRGs, date
Table I. Most common diagnosis-related groups (DRGs) for aortic, cerebrovascular, and peripheral occlusive disease
(POCD) cases
Aortic, No. (%) Cerebrovascular, No. (%) POCD, No. (%)
238 (64), 237 (16), 254 (5),
253 (4), 220 (3), 228 (2)
39 (76), 38 (11), 37 (9) 254 (26), 238 (17), 253 (17), 237 (8),
252 (7), 36 (3), 239 (2), 240 (2)
Table II. Volume, revenue, costs, and margin for aortic
cases for each ﬁscal year (FY) 2010 to 2012
FY 2010 FY 2011 FY 2012
Volume 77 87 92
Revenue $2,291,747 $2,475,673 $3,010,392
Costs $1,439,146 $1,934,407 $2,220,938
Margin $852,601 $541,266 $789,454
Table III. Volume, revenue, costs, and margin for
cerebrovascular cases for each ﬁscal year (FY) 2010 to
2012
FY 2010 FY 2011 FY 2012
Volume 66 84 86
Revenue $753,502 $849,555 $849,143
Costs $325,721 $352,671 $342,933
Margin $427,781 $496,883 $506,210
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deﬁned study categories. Cases were selected from the
Health Quest database.
DRGs associated with vascular surgical procedures
and diagnoses were used to identify cases and subse-
quently grouped into our categories of aortic disease, ce-
rebrovascular disease, and POCD. Revenue and gross
margins were calculated from all accounts that were
paid and loaded into our accounting system (Avega;
MedAssets, Alpharetta, Ga). We used gross margin,
deﬁned as revenue less direct cost, as an approximation
of net margin, deﬁned as revenue less direct and indirect
cost, assuming indirect costs were approximately equiva-
lent across the three study groups. Patient payment,
payer payment, bad debt recovery, and charity care
accounted for revenue. Cost included the direct costs
incurred by the overall care of each patient, including
stafﬁng, medications, operating room time and equip-
ment, and inpatient services such as dietary.RESULTS
During FY 2010, a total of 77 aortic cases were per-
formed. Despite signiﬁcant costs incurred, a gross margin
of $852,601 was achieved. In FY 2011, a moderate in-
crease in cases occurred, leading to a proportional increase
in revenue. However, signiﬁcantly increased costs trans-
lated into a smaller margin of $541,266, only 63% that
of the prior year. FY 2012 also experienced a mild increase
in the total number of aortic cases performed. Again,
overall revenue generated by these cases was more than
in the prior year. The gross margin in FY 2012 did in-
crease to $789,454; however, this remained below the
margin experienced in FY 2010 (Table II). Whereas over-
all aortic volume experienced a 19% increase, the resultant
31% increase in revenue during this period was unable to
offset the 54% increase in costs, leading to a 7% decrease
in gross margin.In FY 2010, we identiﬁed 66 cerebrovascular cases
that generated $753,502 in revenue and $325,721 in
costs, with an overall gross margin of $427,781. During
FY 2011, we performed a moderately increased number
of cerebrovascular cases that led to increased revenue
and increased gross margin as costs remained similar.
Approximately the same number of cerebrovascular cases
were performed in FY 2012, resulting in a gross margin
that was not signiﬁcantly increased from the prior year
(Table III). Overall, cerebrovascular volume increased by
30% and gross margin increased by 18% in this period,
largely in part due to the relatively stable costs across
the study time.
POCD cases accounted for a much larger share of
our practice. In FY 2010, there were 298 cases per-
formed, more than twice the number of aortic and cere-
brovascular cases combined. Even in the face of high
costs, a gross margin of $1,986,014 was attained. Dur-
ing FY 2011, the total number of cases as well as both
revenue generated and costs incurred increased, leading
to a gross margin only 81% that of the prior year. FY
2012 also saw a moderate increase in the total number
of cases, revenue, and costs. However, a gross margin
of $2,293,540 was still realized (Table IV). Despite
a 54% increase in costs for POCD cases during the
study, the 35% increase in volume and 37% increase in
revenue were able to translate into a 15% increase in
gross margin.
Comparison of the mix of endovascular and open
cases in each study category is integral to understanding
of inherent costs and proﬁts realized. Following nation-
wide trends, the proportion of endovascular cases per-
formed is much higher for aortic cases and POCD
cases (Table V). However, in each year reviewed, the to-
tal gross margin generated by aortic and cerebrovascular
cases combined was less than that for POCD cases. In
FY 2010, POCD cases generated 155% more gross
Table V. Percentage open vs endovascular cases for
aortic, cerebrovascular, and peripheral occlusive disease
(POCD) cases for each ﬁscal year (FY) 2010 to 2012
FY 2010, % FY 2011, % FY 2012, %
Aortic
Open 22 17 14
Endovascular 78 83 86
Cerebrovascular
Open 92 94 90
Endovascular 8 6 10
POCD
Open 21 21 21
Endovascular 79 79 79
Table VI. Margin per case for aortic, cerebrovascular,
and peripheral occlusive disease (POCD) cases for each
ﬁscal year (FY) 2010 to 2012
FY 2010 FY 2011 FY 2012
Aortic $11,073 $6221 $8581
Cerebrovascular $6481 $5915 $5886
POCD $6664 $4321 $5705
Table IV. Volume, revenue, costs, and margin for
peripheral occlusive disease (POCD) cases for each ﬁscal
year (FY) 2010 to 2012
FY 2010 FY 2011 FY 2012
Volume 298 371 402
Revenue $4,433,904 $4,967,958 $6,062,359
Costs $2,447,890 $3,364,684 $3,768,819
Margin $1,986,014 $1,603,274 $2,293,540
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For FY 2011, POCD cases generated 154% of the gross
revenue of the combination of aortic and cerebrovascular
cases. In FY 2012, the disparity widened, with POCD
cases generating 177% more gross revenue than aortic
and cerebrovascular cases. The difference in gross revenue
achieved is largely volume driven. On a case-by-case basis,
the margin per case for POCD was shown to be less than
that for aortic or cerebrovascular cases in the years studied.
Aortic procedures yielded the greatest per-case margin;
however, the gap between aortic and cerebrovascular
cases or POCD cases shrank with each subsequent year
(Table VI).
Unlike aortic disease or cerebrovascular disease, POCD
has a robust outpatient practice. Further analysis of our
POCD ﬁndings led to the breakdown of revenue, cost,
and margin analysis for procedures performed on an inpa-
tient vs an outpatient basis. In each year studied, the num-
ber of inpatient vs outpatient POCD cases performed was
approximately the same. The revenue generated, costs
accrued, and gross margin produced by the outpatient
POCD cases were only a small proportion of the totals
for each year studied, underlining the overall importance
and ﬁnancial impact of the inpatient component of
POCD interventions. However, during the study period,
outpatient POCD procedures accounted for an increasing
percentage of gross margin with each year, from 22.2%
to 24.9% to 30.7%, while simultaneously accounting for a
smaller proportion of costs, from 17.9% to 17.1% to
13.6% (Table VII).DISCUSSION
In a national effort to curb the costs of health care,
substantial changes have been made to the structure of
reimbursement for medical care.1,2 To balance cost
with revenue, health care systems have reﬂected on inter-
nal practices to ensure ﬁnancial viability.4,5,8 As such, the
vascular surgery community must be vigilant with respect
to the costs and the impact of the care it delivers in the
face of ever-changing system standards.3,6 With the
implementation of the Patient Protection and Affordable
Care Act, changes to imaging reimbursement, to equip-
ment utilization rates, and to other aspects of care are
likely to have a signiﬁcant impact on the practice of
vascular surgery. In addition, as the focus of vascular sur-
gery increasingly favors endovascular intervention, which
has already been shown to impart greater cost because of
the inherent costs associated with endovascular devices,
controlling other aspects of cost is imperative to
increasing margins.6,8,9 It was recently shown that even
in centers with lower than average length of stays, Medi-
care reimbursements for endovascular interventions fail
to provide positive technical margins.11 For sustainable
care to be provided, more attention must be focused
on the ﬁnancial implications of vascular surgical care. In
this study, we reviewed our three most robust areas of
care to investigate which practices translate into greater
margins.
We have previously demonstrated the positive ﬁnan-
cial impact of an academic vascular program on a health
care system.9 In this study, we have broken down aspects
of our vascular care to identify the area that has the
greatest ﬁnancial impact in our practice, which has
been shown to be POCD despite its high cost. Even
though overall costs for POCD were 139%, 147%, and
147% those for aortic and cerebrovascular cases com-
bined for each year studied, the gross margins were pro-
portionately higher in each year studied at 155%, 154%,
and 177%, underlining both its ﬁnancial importance and
growing impact on the viability of our practice. On a
per-case basis, POCD does not yield the highest gross
margin; however, during the period studied, we experi-
enced a greater ﬁnancial impact from POCD procedures.
The overall proﬁtability of POCD appears to be driven
largely by volume, with nearly twice as many peripheral
occlusive procedures performed annually compared
with other procedures in this study.
Table VII. Volume, revenue, costs, and margin for inpatient vs outpatient peripheral occlusive disease (POCD) cases for
each ﬁscal year (FY) 2010 to 2012
FY 2010 FY 2011 FY 2012
Inpatient (% total) Outpatient (% total) Inpatient (% total) Outpatient (% total) Inpatient (% total) Outpatient (% total)
Volume 154 (51.7) 144 (48.3) 184 (49.6) 187 (50.4) 192 (47.8) 210 (52.2)
Revenue $3,554,659 (80.2) $879,245 (19.8) $3,993,045 (80.4) $974,912 (19.6) $4,843,725 (79.9) $1,218,635 (20.1)
Costs $2,010,277 (82.1) $437,614 (17.9) $2,789,140 (82.9) $575,544 (17.1) $3,254,534 (86.4) $514,285 (13.6)
Margin $1,544,382 (87.8) $441,631 (22.2) $1,203,905 (75.1) $399,368 (24.9) $1,589,191 (69.3) $704,350 (30.7)
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interventions underscore the importance of controlling
expenses to maximize revenue. Multiple studies have
been undertaken in the last couple of decades to identify
how resources can be managed to develop best-practice
plans and to implement methods targeted at standard-
izing care and controlling costs.3,5,8 Multidisciplinary
patient management and quality control initiatives have
been shown to help reduce length of stay and increase
patient volume, both helping to augment revenue. We
have demonstrated similar outcomes in our practice
with the implementation of a nurse practitioner program
and care pathways.9
CONCLUSIONS
We sought to review three main areas of our practice to
determine which aspects of the care we deliver provide the
greatest margins. POCD cases generated the most revenue,
cost, and margin in comparison to those of aortic and cere-
brovascular cases combined, and this was largely based on
overall volume of cases. Whereas this was strictly a retro-
spective review of care provided in one large academic ter-
tiary care center, healthy reﬂections on practice patterns
can identify which interventions impart greater margins in
the face of decreasing reimbursements. Further investiga-
tion and time are needed to determine more deﬁnitively
how to decrease costs and to increase margins while main-
taining or improving quality.
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